ARCHIVES

DCCP Board Defers Two Concept Requests, Approves Sole Sources

This article is from The Cancer Letter archive.

Vol. 08 No. 41 | October 22, 1982

Download PDF Visit The Full Archive

Related Articles

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Organ Site Program Fate On Line, Gets Review Next Week

November 20, 1981

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

ASCO Picks University of Michigan Medical School Dean Allen Lichter As Exective Vice President and CEO.

July 14, 2006

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984